615.1 — Фармация. Аптечное дело

CASSIA SENNA (SENNA ALEXANDRINA) LEAVES AS A PROSPECTIVE SOURCE OF ANTI-ULCER THERAPEUTICS IN NIGERIA: An Ethnopharmacological, Phytochemical, and Drug Discovery Perspective Mabrig Korie · 2026

Herbal Supplements and Anti-Tuberculosis Therapy: Unlocking Hidden Interactions for Better Multidrug-Resistant Tuberculosis Management Siva Bhukya, Ravi Adinarayan Somabattini, Neelanjan Chowdhury, Sathi Sarkar, Anish Das · 2026

Comparative efficacy of transcutaneous tibial nerve stimulation (TTNS) versus solifenacin in female patients with overactive bladder MohammadJavad Safaie Yazdi, Salman Nazary-Moghadam, Bagher Soleimani, Seyyed Parham Ahmadi, Fatemeh Sadabadi · 2026

CASSIA SENNA (SENNA ALEXANDRINA) LEAVES AS A PROSPECTIVE SOURCE OF ANTI-ULCER THERAPEUTICS IN NIGERIA: An Ethnopharmacological, Phytochemical, and Drug Discovery Perspective Mabrig Korie · 2026

Ca v 3.2 T‐type calcium channels in chronic pain: Structural insights, pharmacological advances and challenges in subtype selectivity Lu Fu, Wanbin Huang, C. F. Xu, Yi Zhou, Heyang Qin · 2026

The Economic Impact of Cumulative Metabolic Comorbidity Burden in Schizophrenia: A Claims-Based Analysis of Medical Costs in the United States Xue Han, Seth C. Hopkins, Zhen Zhang, S Awasthi · 2026

Self-medication with herbal remedies and pharmaceuticals for COVID-19 among healthcare students in Maputo Esperança João Rafael, Filomena Barbosa, Saquina Rugunate, Delfina Fernandes Hlashwayo · 2026

Benchmark Survey on Content Development and Key Performance Indicators: A phactMI Benchmarking Survey Update Robert Tamburri, Mary K. Sendi, Anja Glaetzer, Jennifer Garas, Mary Mehrabian · 2026

Patterns of medication use across society from national primary care dispensing data Caroline E. Dale, Rohan Takhar, Andrew Lambarth, Andrew Mason, Nathalie Conrad · 2026

Potassium-competitive acid blockers and proton-pump inhibitors for the healing and maintenance of erosive esophagitis: a comprehensive and updated systematic review with network meta-analysis Daniel Martin Simadibrata, Thai Hau Koo, Raúl Alberto Jiménez‐Castillo, Ronnie Fass · 2026

Italian regional data and oropharyngeal adverse events to drugs and vaccines: insights from a 3-year spontaneous reporting (2022–2024) Liberata Sportiello, Mario Gaio, Alessia Zinzi, Gaetano La Mantia, Vera Panzarella · 2026

SKYVaricella (a live attenuated varicella vaccine) safety issues revisited Joowon Lee · 2026

Computational Pipelines for Disease-Specific Drug Repurposing Mena Abdelsayed · 2026

Model-informed dose optimization of carvedilol and nebivolol in cirrhotic patients: a pilot randomized clinical study Mai Tarek, Ahmed A Ali, Reda Biomy, Khaled Abdelkawy, Eman El‐Khateeb · 2026

Update on Glucocorticoid-Induced Osteoporosis: Emerging Therapeutic Strategies Soo‐Kyung Cho, Yoon‐Kyoung Sung · 2026

Data and materials for "Reporting patterns of adverse drug withdrawal events using individual case safety reports in United States and European databases" Zakir Khan, Frank Moriarty · 2026

KAN-PROSPECT: a Kolmogorov–Arnold Networks–integrated framework for predicting the effects and adverse reactions of natural products via transfer learning Zhenshun Du, Zi Wang, Yuehua Chen, Boyou Li, Xin Wan · 2026

Clinical patterns and pharmacovigilance trends of cutaneous adverse drug reactions in India Kajomi Shingala, Dipesh Nariya · 2026

Anthelmintic medication with focus on first-trimester exposure: an evaluation of pregnancy outcomes based on the Embryotox cohort Laura Heineke, Evelin Beck, Reinhold Kreutz, Katarina Dathe · 2026

ТЕРРИТОРИАЛЬНО-ОТРАСЛЕВАЯ ДИФФЕРЕНЦИАЦИЯ СОЦИАЛЬНЫХ ПРЕДПРИЯТИЙ В ОТЕЧЕСТВЕННОЙ МЕДИЦИНЕ И ФАРМАЦИИ Загузова Елена Владимировна, Глембоцкая Галина Тихоновна, Абросимова Наталья Васильевна · 2025

Unregulated Peptide Use in the Age of Biohacking: Digital Promotion, Gray-Market Access, and Emerging Public Health Risks Kirubel T Hailu, Feven Negasi Abriha, Yeabsera M Duguma, Ryan R Haddad, Tewodros Liyew · 2026

Artificial intelligence–powered chatbots for oral anticancer drug patient information: an assessment of quality Sophie M. Sametinger, Renke Maas, Hagen Fabian Nicolaus, Wahram Andrikyan · 2026

Efficacy of plant extracts in heart failure patients: a systematic review and network meta-analysis Tianjiao Tang, Guang Li, Xiaoqian Huang, Hongsheng Liang · 2026

Quieting the Mind, Healing the Body: Guided Imagery and Mindfulness Meditation among Cancer Patients Gireesh Giriyapura Rudrappa, Leena Kunnath Chacko · 2026

Repositioning Tradition: A Narrative Review and Expert Opinion on the Clinical Positioning of Glimepiride and Metformin in Nepal's Type 2 Diabetes Mellitus (T2DM) Landscape Sabin Chaulagain, Madhu pandey, Subesh Saurav, Dipak Malla, Krishna Kumar Agrawal · 2026

Real-world and computational identification of herbal candidates associated with adverse event patterns in glucagon-like peptide-1 therapy for obesity Junkyu Park, Sujin Shin, Yong Wook Kim, Jaiwha Seo, B R Kim · 2026

Treatment-related pain in refractory cancer pain: prevalence, mechanisms, and clinical implications in a tertiary referral cohort Rotem Agur, Barak Cohen, Mulham Sabbah, Silviu Brill, Maor Staierman · 2026

A treadmill training program in a gamified virtual reality environment combined with transcranial direct current stimulation in Parkinson’s Disease: Preliminary results of a mixed methods randomized controlled trial Pere Bosch‐Barceló, Carlos Tersa-Miralles, Oriol Martínez-Navarro, Maria Masbernat-Almenara, Anni Pakarinen · 2026

Successful rescue therapy with eculizumab for probable tislelizumab-related MMM overlap syndrome with dual positivity for anti-acetylcholine receptor and anti-titin antibodies: a case report and literature review Li Y, Yanlei Hao · 2026

Melatonin and cerium oxide nanoparticles additively mitigate capecitabine-induced hepatotoxicity via targeting oxidative stress, apoptosis, and ERK signaling Khalid M. Mohany, Heba M. Elkady, Nashwa Hamad, Sahar E. M. El-Deek · 2026

Erythropoiesis and Red Cell Disorders After Hematopoietic Stem Cell Transplantation: Mechanisms, Diagnostics, and Clinical Management Brandon Tang, Grace Kim, Tiffany Chen, Hien Lau and Eric L. Tam · 2026

Acute and chronic kidney injury following COVID-19 infection and vaccination: a narrative review Seyed Hassan Saadat, Mohammad Javanbakht, Hossein Amini, Mahboubeh Rouhollahei, Luca Cegolon · 2026

Therapeutic Drug Monitoring of Cannabinoids: Therapeutic Reference Ranges for Delta-9-tetrahydrocannabinol in Medical Cannabis, Nabiximols, Dronabinol and Nabilone Friederike Amann, Gudrun Hefner, Peter Cremer-Schaeffer, Gerhard Gründer, Winfried Häuser · 2026

A COMPREHENSIVE OVERVIEW OF ANTIDIABETIC DRUG'S SAFETY PROFILE USING WHO – UMC SCALE *Aryan Srivastava, Surabhi Dwivedi, Asheesh Pratap Singh · 2026

Clinical effects of lamotrigine combined with duloxetine in the treatment of bipolar depression Xiaokang Wang, 豊杉山, Yuxian Chen, Gengrui Xu, Lin Jiang · 2026

A COMPREHENSIVE OVERVIEW OF ANTIDIABETIC DRUG'S SAFETY PROFILE USING WHO – UMC SCALE *Aryan Srivastava, Surabhi Dwivedi, Asheesh Pratap Singh · 2026

Recaticimab: The First Fc-Engineered PCSK9 Monoclonal Antibody for More Long-Lasting Effect in Lipid Lowering S N Li, Gao Y, Cheng-Gang Zhu, Jian‐Jun Li · 2026

Differentiation of intellectual disability (ID) with depressive symptomology versus psychotic disorder utilizing multidisciplinary approach case report Mandolin F. Barberito, Isabelle V. Mermilliod, Elizabeth M. Bozner, Erik N. Hanson, Jeremiah A. Henning · 2026

Genetically supported drug target prioritization for rare diseases Robert Chen, Áine Duffy, Matthew Mort, David N. Cooper, Ghislain Rocheleau · 2026

The Danish Region Midt Schizophrenia Cohort - Representative, long-term follow-up of first-episode schizophrenia spectrum disorder Nina Friis Bak Fuglsang, Anne Lund, Susanne Olesen, Pia Høgh, Anne-Louise Egholm Stagis · 2026

Digital Rehabilitation Following Ultrasound-Guided Injection for Chronic Rotator Cuff Injury: Randomized Controlled Trial Zifu He, Y Zhang, Liyan Shi, Gaineng Yuan, Xuefeng Liu · 2026

Cost-effectiveness of semaglutide versus dulaglutide for Type 2 Diabetes in China: A Markov Model analysis Qiying Chen, Tianyu Chen, Weicheng Lin, Xi Chen · 2026

Long-Term Antidepressant Use and Dementia Risk: A Propensity Score-Matched Study of Swiss Older Adults, with an Anticholinergic-Specific Analysis Melanie A. Amrein, Michael P. Hengartner, Markus Näpflin, Renato Farcher, Carola A. Huber · 2026

Development and psychometric testing of a parental knowledge, attitude, and practices questionnaire on pentavalent vaccine safety Feroze Fathima, MAHESH MAHADEVAIAH NOSENOOR · 2026

A Retrospective Pharmacovigilance Disproportionality Analysis of Possible Nephrotoxicity and Natural Products Using Data from the FDA Adverse Event Reporting System Caiden J. Lukan, Iman Karimzadeh, Tiffany L. Tran, Maryann R. Sestito, Kojo Abanyie · 2026

Clinical outcomes of teduglutide therapy in children with short bowel syndrome–associated intestinal failure: A single-center experience Mariah Mukasa, Hadar Moran‐Lev, Lindsey Hornung, Samuel A. Kocoshis, Stephanie B. Oliveira · 2026

HIV resistance to integrase strand-transfer inhibitors: disproportionality analysis of individual case safety reports from the WHO global safety database (VigiBase) Helena Sclauser Basílio, Adriano Max Moreira Reis, Letícia Penna Braga, Laura Beatriz Fonseca, Paula Lana de Miranda Drummond · 2026

Analysis of adverse drug reactions reported at a teaching hospital in 2023–24 S Tewari, M Bankar, Puja, Nagi Reddy · 2026

New Tuberculosis Infection and Reactivation of Tuberculosis in Patients with Psoriasis or Psoriatic Arthritis Receiving IL-23 Inhibitors: A Systematic Literature Review G Wang, Sang Woong Youn, Chia-Ling Chang, Hidehisa Saeki · 2026

Pharmacovigilance for Health Management: A National Profile of Methylphenidate Adverse Events in Thailand Using National Databases Suwapat Sukthas, Pornpan Soontorntham, Surasak Saokaew · 2026

Efficacy and safety of CGRP monoclonal antibodies in chronic migraine: a systematic review integrating randomized and real-world evidence Diamante Carta, Viviana Lo Buono, Rosario Grugno, Riccardo Lo Presti, Angelo Quartarone · 2026

Inequities in enrollment across clinical trial phases and the need for a Spanish perspective Javier Torres-Jiménez, Javier David Benitez Fuentes, Monica Guillot Morales, Patricia Palacios Ozores, Ana I. Ruiz-Casado · 2026

Autism Spectrum Disorder and Cardiovascular Risk: The Role of Frontal QRS–T Angle and Systemic Immune-Inflammation Index Umut Balatacı, Bari Ay · 2026

ПРИНЦИП ИЕРАРХИЧНОСТИ В ОБЕСПЕЧЕНИИ ЭКОНОМИЧЕСКОЙ БЕЗОПАСНОСТИ В ФАРМАЦИИ Кузнецов Д. А. · 2023

Цифровая трансформация фармацевтической отрасли: роль искусственного интеллекта в фармации Паршенков Михаил Алексеевич, Романов Филипп Александрович, Яворский Александр Николаевич · 2026

ПЕРСПЕКТИВЫ РАЗВИТИЯ АПТЕЧНОГО СКЛАДА ВИТЕБСКОГО УП «ФАРМАЦИЯ» Е. С. Борисеевич · 2024

Hair Loss in Patients on Glucagon-Like Peptide 1 Receptor Agonists: Understanding Risks and Managing Outcomes Bianca Maria Piraccini, Sergio Vañó-Galván, Ulrike Blume-Peytavi, Virginie Ribet, V. Mengeaud · 2026

Risk of drug-related aggression in pediatric populations: a pharmacovigilance analysis using the FAERS database Jing Chen, Lilan Zhao · 2026

Safety of BNT162b2 COVID-19 Vaccine in Pregnancy: A Systematic Review Elizabeth Thoburn, Vassilis G. Giannakoulis, Tianyan Hu, Henry Goebe, Sheetal Raina · 2026

From tradition to therapy: novel clove formulations in periodontal therapy Himanshu Yadav, Ritesh Kumar Tiwari, Shashi Verma · 2026

Management of gynecomastia in adolescence and adults: the clinical practice guidelines from the Italian Society of Andrology and Sexual Medicine (SIAMS) Carlotta Pozza, Riccardo Selice, A Barbonetti, Valeria Hasenmajer, Francesco Lotti · 2026

The stand-alone Ayurveda treatment for the management of COVID-associated mucormycosis (CAM): a case report Rajnikant Patel, skanthesh Lakshmanan, Vinayak Padikkal, Keyur Mandaliya · 2026

Comparative pharmacovigilance of herpetic infections with dupilumab and JAK inhibitors in atopic dermatitis Yaning Tian, Meixuan Li, Haoyang Hong, Rongfang Feng, Mai Luo · 2026

Comparative post-marketing reporting signals of elagolix and myfembree in endometriosis: a FAERS pharmacovigilance study MengLong Bai, Shiju Shen, Jin-Yuan Chen · 2026

The neurological adverse events of immune check point inhibitors in the treatment of cancer Ahmad A. Toubasi, Thuraya N. Al‐Sayegh · 2026

History repeats in sweet solutions: toxicological concerns and targeted recommendations following the cough syrup-linked paediatric mortalities in India K S Suhas, Kaveri Jambagi, Swati Koli · 2026

Relationship between medication class and ambulatory blood pressure profile in the chronic renal insufficiency cohort (CRIC) study Sachin V. Pasricha, Debbie L. Cohen, Rachel Shulman, R Byfield, Jordana B. Cohen · 2026

Fulminant Myocarditis with Combination Immune Checkpoint Blockade Douglas B. Johnson, Justin M. Balko, Margaret Compton, Spyridon Chalkias, Joshua Gorham · 2016

Bacteriophage therapy against multidrug resistant bacterial infections demonstrates clinical advances and engineering innovations between 2020–2026 Ahmed J. Alzahrani · 2026

Coagulation dysfunction events associated with novel tetracycline-class drugs: a disproportionality and Bayesian analysis based on the FAERS database Hongxin Li, Jun Wang, Lingjun Kong, Qingwang Wei, Chengwu Shen · 2026

Phthalocyanine-based mouth gel as an adjunct to non-surgical periodontal treatment: a randomized controlled trial Sebastião Orestes Pereira Neto, Pedro Luiz Rosalen, João Vitor da Cruz Pegoraro, Isadora Stella Souza e Andrade, Ana Luiza Marques Reis · 2026

Stimuli-responsive nanogels as intelligent nanocarriers for tumor microenvironment-triggered anticancer drug delivery Ankita Wal, Sarad Pawar Naik Bukke, Nithin Vidiyala, Shahid Jamil, K K Sharma · 2026

Frailty and sex differences in blood pressure control in older adults Tan Van Nguyen, Vien Thi Nguyen, Wei Jin Wong, Erkihun Amsalu, Trinh Kim Thi Ngo · 2026

Golimumab-associated myocarditis with progressive eosinophilia after route switch in rheumatoid arthritis Stephanie Ammari, Nawras Ibrahim · 2026

Ivermectin in veterinary medicine: a narrative review of antiparasitic efficacy, resistance evolution, antiviral evidence, and One Health implications Matthew Halma, Joseph Varon, Valeria Garcia, Sidra Hassaan, Jack Tuszynski · 2026

A case report and literature review of proton pump inhibitors inducing insulin autoimmune syndrome Wenrui Zhang, Jiayan Wen, Siming Qi, Guohui Zhang, Xubin Yang · 2026

Evidence-based AI: from trailblazer to trustblazer? Thomas Luechtefeld, Thomas Hartung · 2026

Adverse event mining for Breztri and Trelegy Ellipta based on the three international pharmacovigilance databases Yì Wáng, Kexu Chen, Lu Yun, Dexiang Xu · 2026

Drug-related pulmonary fibrosis: A real-world pharmacovigilance study of the FDA Adverse Event Reporting System Ruonan Jian, Lei Yang, Jingjing Guo, Erxia Shi, Mingyan Du · 2026

Remote cognitive-motor dual-task training and cognition in mild cognitive impairment: a randomized controlled trial Jing Cui, Li Song, Jing Du (264116), Zhiming Bian, Xiaoyi Wang · 2026

Economic Impact of Timely Systemic Treatment of Psoriatic Disease in Comorbidity Risk Reduction: Literature Review and (Early) Economic Assessment Nicholas Norton, Zoltan Nemeth, Soumya Nanda, Abhishek Dhirta, Kirk Geale · 2026

Cognitive impairment patterns and associated clinical and imaging characteristics in young patients with Sturge-Weber syndrome Halah Z. Keramane, Michael E. Behen, Aimée F. Luat, Csaba Juhász · 2026

Real-world efficacy and safety profile of four JAK inhibitors in rheumatoid arthritis: a French single-center observational study Salomé Abdellaoui, Omar Al Tabaa, Stéphane Hilliquin, Roberto d’Alessandro, Sophie Hecquet · 2026

Pustules in Stevens-Johnson Syndrome Shunya Nagata, Takaie Kuki, Miyuki Kato · 2026

Unveiling medication patterns in traditional Chinese medicine for the prevention of colorectal cancer recurrence: from potential combinations to validation of components and targets Qianqian Bu, Shaoxun Yuan, Xiaoman Wei, Junyi Wang, Liu Li · 2026

The association between age and medication-related hospital admission in adults: a systematic review and meta-analysis Reema Mohammad Munshi, Eimear Ní Sheachnasaigh, Monica Strugaru, Folasade Olawoye, Catherine Comiskey · 2026

Antiparasitic triterpenic ester and ursolic acid lipid nanocapsule design, cytotoxicity, and permeability evaluation for oral delivery Laura Schioppa, Cécilia Bohns Michalowski, Lúcia Mamede, Romano Terrasi, Marie‐France Hérent · 2026

Pharmaceutical quality and cost-effectiveness of branded versus generic medicines across 22 drug types and 8 therapeutic categories: a citizen-funded comparative study from regulated retail outlets in Kerala, India Cyriac Abby Philips, Arif Hussain Theruvath, Aryalakshmi Sreemohan, Ambily Baby, Shinsmon Jose · 2026

Review on biological active metabolites of Astragali radix and its mechanisms in treating allergic respiratory diseases Z Wang, Jie Cui, Shaoyan Zhang, Yu Wang, Lei Qiu · 2026

Development and validation of a machine learning-based clinical decision support tool for stratifying intravenous medication risk in hospitalized patients with heart failure Y S Yang, 徐泽杰, Yu Peilin, Hui Li, Hongmei Wang · 2026

ASSESSMENT OF NEUROPSYCHIATRIC ADVERSE DRUG REACTIONS ASSOCIATED WITH MONTELUKAST: A PHARMACOVIGILANCE DATABASE STUDY Dr. Padige Sri. Varsha¹, Vallela Niveditha Reddy²*, Madiha Faiyaz Ahmed², Asfiya Anjum², Swapna Kindoddi² · 2026

Drug–Drug and Drug–Disease Interactions Across Antidiabetic Drug Classes: A Narrative Review and Practical Recommendations Cristina-Elena Zbârcea, Cristian‐Daniel Marineci, Andrei Valeanu, Cornel Chiriţă, Oana-Cristina Şeremet · 2026

Post-marketing safety profile of palivizumab: a 20-year pharmacovigilance study using the FDA Adverse Event Reporting System (FAERS) Qing Yan, Yuke Zhong · 2026

ASSESSMENT OF NEUROPSYCHIATRIC ADVERSE DRUG REACTIONS ASSOCIATED WITH MONTELUKAST: A PHARMACOVIGILANCE DATABASE STUDY Dr. Padige Sri. Varsha¹, Vallela Niveditha Reddy²*, Madiha Faiyaz Ahmed², Asfiya Anjum², Swapna Kindoddi² · 2026

REVIEW ON AI IN DRUG SAFETY AND EFFICACY ASSESSMENT Pawan Patidar*, Mrs. Kajal Mudgal · 2026

Phytotherapy in aquaculture as a sustainable alternative to antibiotics for disease management Aishwarya Sharma, Gowhar Iqbal, Nahida Quyoom, Naresh Raj Keer, Dharmendra Kumar Meena · 2026

Gabapentin and Pregabalin Use in First Trimester of Pregnancy and Risk of Specific Congenital Anomalies: An IMI ConcePTION European Case-Malformed Control Study Anna-Belle Beau, Erika Cifuentes Castro, Justine Benevent, Marie Beslay, Laia Barrachina-Bonet · 2026

Pharmacovigilance Analysis of Bleeding Events Associated With Selective Serotonin Reuptake Inhibitors (SSRIs) Using the US Food and Drug Administration Adverse Event Reporting System (FAERS) Adrian Chin Yan Chan · 2026

Beyond Molecular Structures: Investigating Demographic Factors in Drug-Induced Cardiotoxicity Prediction Models Mateusz Iwan, Alessandra Roncaglioni, Francesca Grisoni · 2026

PHARMACOVIGILANCE IN AYURVEDA: INTEGRATING CLASSICAL DRUG SAFETY PRINCIPLES WITH CONTEMPORARY PHARMACOVIGILANCE SYSTEMS *1Dr. Chandni Gupta, 2Prof. Rashmi Srivastava, 3Dr. Vishal Nanda · 2026

REVIEW ON AI IN DRUG SAFETY AND EFFICACY ASSESSMENT Pawan Patidar*, Mrs. Kajal Mudgal · 2026

PHARMACOVIGILANCE AND HERBAL MEDICINE SAFETY: A COMPRIHENSIVE REVIEW Neelam Thakur*, Harsh Thakur, Kavita Pathania, Pooja Sharma · 2026

Efficacy and safety of repetitive transcranial magnetic stimulation in anorexia and bulimia nervosa: a systematic review and meta-analysis Dalia Kamal Ewis, Haneen Sabet, Yousef Hawas, Wajeeh Hassan, Moaz Elsayed Abouelmagd · 2026

Milrinone in late tetralogy of Fallot repair: physiologic rationale, clinical evidence, and perspectives from low- and middle-income countries—a state-of-the-art review Joram Lawrence Nyandat · 2026

Mechanism study on the intervention of type 2 diabetes mellitus by whole bitter melon beverage Yidan Zhang, Yihui Wang, Xiaoyun Cao, Si Huang, Taotao Dai · 2026

Safety profile of empagliflozin in clinical practice: A scoping review of real-world evidence Malwatta MALD, Wasana PWD, Gunawardena S · 2026

Multi-Relational Knowledge Graph for Drug Repurposing and Side-Effect Burden Prediction Using Gene–Drug–Disease Associations Afsana Sharmin, Bahar Uddin Mahmud · 2026

Sirolimus Therapy and Dyslipidemia in Neonates and Infants: A Retrospective Cohort and Pharmacovigilance Analysis Akinobu Taniguchi, Basile Chrétien, Takashi Maeda, Kazuto Ueda, Ryosuke Miura · 2026

Facilitators and Barriers to the Uptake of the Med Safety App for Reporting Adverse Drug Reactions in Ghana: A Mixed-Methods Approach Seth Kwaku Seaneke, Margaret Gyapong, Edwin Nkansah, Delese Mimi Darko, Adela Ashie · 2026

Reversible alterations of brain acetate metabolism associated with alcohol consumption Chathura Kumaragamage, Lihong Jiang, Gustavo A. Angarita, Robin A. de Graaf, Elizabeth Guidone · 2026

PromptSE: drug side effect prediction with LLM-derived pharmacological representations Yuqing Xia, Hao Wang, Tianyi Li, Yilong Niu · 2026

Longitudinal clinical response to Janus kinase inhibitors in systemic sclerosis: a real-life multicentric study across multiple clinical domains S Di Donato, Juan José Alegre-Sancho, Анастас Баталов, Z. Batalov, Silvia Bellando-Randone · 2026

COMPARATIVE STUDY OF REGULATORY REQUIREMENTS FOR DRUG APPROVAL PROCESS IN UNITED STATE, INDIA AND EUROPE UNION Priyanka Padole1*, Prof. (Dr.) M.A. Channawar2, Prof. (Dr.) A. V. Chandewar3 · 2026

PHARMACOVIGILANCE IN AYURVEDA: INTEGRATING CLASSICAL DRUG SAFETY PRINCIPLES WITH CONTEMPORARY PHARMACOVIGILANCE SYSTEMS *1Dr. Chandni Gupta, 2Prof. Rashmi Srivastava, 3Dr. Vishal Nanda · 2026

ROLE OF COMMUNITY PHARMACISTS IN ADR MONITORING: A COMPREHENSIVE REVIEW Anju K. R.*1, Shruti Palaskar2, Nikita Yadav3, Bhavesh Choudhary4, Sanjiv Vishwakarm5, Shrutika Patil6 · 2026

ARTIFICIAL INTELLIGENCE IN PHARMACOVIGELLANCE: EMERGING DRUG SAFETY MONITORING 1*Ms. Shital Masurkar, 2Prof. Suraj P. Rajurkar, 3Dr. Karishma A. Nikose, 4Prof. Suraj Thakare, 5Prof. Neha Naringe, 6Prof. Mrunal D. Thakare · 2026

PHARMACOVIGILANCE AND HERBAL MEDICINE SAFETY: A COMPRIHENSIVE REVIEW Neelam Thakur*, Harsh Thakur, Kavita Pathania, Pooja Sharma · 2026

Turning failure into success: how artificial intelligence can help personalize therapies and re-use patient data Maria P. Abbracchio, Ernesto Damiani · 2026

Bacterial biofilms and antimicrobial resistance: a global threat Lucy Musa Yaki · 2026

Interventions to improve neonatal and infant intubation success: a meta-analysis Wenla Tjurin, Panu Kiviranta, Heli Salmi, Ilari Kuitunen · 2026

IMPACT OF CDC PANCHAKARMA PROTOCOL WITH PRAMEHA DIET BOX ON GLYCEMIC CONTROL AND REDUCTION OF ANTIDIABETIC MEDICATIONS IN TYPE 2 Dr. Rohit Sane1, Dr. Gurudatta Amin2, Dr. Pravin Ghadigaonkar3, Dr. Nilesh Kulthe*4, Dr. Priyanka Salwade5 · 2026

ROLE OF COMMUNITY PHARMACISTS IN ADR MONITORING: A COMPREHENSIVE REVIEW Anju K. R.*1, Shruti Palaskar2, Nikita Yadav3, Bhavesh Choudhary4, Sanjiv Vishwakarm5, Shrutika Patil6 · 2026

ARTIFICIAL INTELLIGENCE DRIVEN PHARMACOVIGILANCE INNOVATION IN DRUG SAFETY Rathore Vivek Singh*, Sawner Yashraj, Dawar Sachin, Jaiswal Manoj · 2026

IMPACT OF CDC PANCHAKARMA PROTOCOL WITH PRAMEHA DIET BOX ON GLYCEMIC CONTROL AND REDUCTION OF ANTIDIABETIC MEDICATIONS IN TYPE 2 Dr. Rohit Sane1, Dr. Gurudatta Amin2, Dr. Pravin Ghadigaonkar3, Dr. Nilesh Kulthe*4, Dr. Priyanka Salwade5 · 2026

COMPARATIVE STUDY OF REGULATORY REQUIREMENTS FOR DRUG APPROVAL PROCESS IN UNITED STATE, INDIA AND EUROPE UNION Priyanka Padole1*, Prof. (Dr.) M.A. Channawar2, Prof. (Dr.) A. V. Chandewar3 · 2026

ARTIFICIAL INTELLIGENCE IN PHARMACOVIGELLANCE: EMERGING DRUG SAFETY MONITORING 1*Ms. Shital Masurkar, 2Prof. Suraj P. Rajurkar, 3Dr. Karishma A. Nikose, 4Prof. Suraj Thakare, 5Prof. Neha Naringe, 6Prof. Mrunal D. Thakare · 2026

ARTIFICIAL INTELLIGENCE DRIVEN PHARMACOVIGILANCE INNOVATION IN DRUG SAFETY Rathore Vivek Singh*, Sawner Yashraj, Dawar Sachin, Jaiswal Manoj · 2026

COMPREHENSIVE REVIEW PAPER MIMOSA PUDICA IN THE TREATMENT OF MIGRAINE Gaikwad Akanksha Navnath, Chavan Rutuja Sunil, Ghadigaonkar Darshana Suresh, Giri Datta Balaji, Panmad Priyanka Kashinath · 2026

Botulinumtoxin Type-A (BoNTA) in the Management of Refractory Trigeminal Neuralgia: An Expert-Opinion, Practice-Oriented Narrative Review on Behalf of the GRASP Study Group Andreas A. Argyriou, Emmanouil V. Dermitzakis, Dimitrios Rikos, Georgia Xiromerisiou, Panagiotis Soldatos · 2026

Impact of an Educational Intervention on Knowledge, Attitude, and Practice of Adverse Drug Reaction Reporting: A Comparative Study Among Pharmacy Students and Hospital Pharmacists in a Tertiary Care Setting Anjali Shinde, Vandana Thorat, Saloni Koli, Pratibha Salve, Smita Surale-Patil · 2026

Disproportionate reporting of severe gastrointestinal injury with ruxolitinib among JAK inhibitors in myeloproliferative neoplasms: A FAERS pharmacovigilance analysis. Sufian Sorathia, A Sorathia · 2026

From Pills to Pixels: Why Software as a Medical Device Will Redefine Pharmacovigilance Varun Kumar Gone · 2026

Antibiotic-Induced Manic Episodes: Clinical Recognition, Mechanistic Pathways, and Management Eunsung Lim, Chi Eung Danforn Lim · 2026

COMPREHENSIVE REVIEW PAPER MIMOSA PUDICA IN THE TREATMENT OF MIGRAINE Gaikwad Akanksha Navnath, Chavan Rutuja Sunil, Ghadigaonkar Darshana Suresh, Giri Datta Balaji, Panmad Priyanka Kashinath · 2026

MORPHIN - A SYSTEMATIC REVIEW Dr. G. V. Paunikar, Ms. Shraddha R. Wasnik*, Mr. Ratikesh A. Wawarkar, Mr. Swapnil R. Dudhakohar · 2026

Disproportionate reporting of ischemic gastrointestinal injury associated with lenvatinib: A FAERS pharmacovigilance analysis. Sufian Sorathia, A Sorathia · 2026

Global Safety Monitoring Of Covid-19 Vaccine In Pharmacovigilance Shilanand Pattebahadur, Shubham Vaidya · 2026

Compatitive pharmacovigilance study of clozapine and it's safer substitutes in schizophrenia management Diksha chandrashekhar Lohana · 2026

Beyond opioid dosage: temporal dynamics of intravenous patient-controlled analgesia use captured by electronic device logs—a post hoc analysis of three randomized controlled trials Sooah Cho, Soo‐Hyuk Yoon, Ho-Jin Lee · 2026

Therapeutic potential of combining mirogabalin with antidepressants in relieving hypersensitivity: evidence from a mouse model of neuropathic pain Renata Zajączkowska, A Ciechanowska, Katarzyna Pawlik, Katarzyna Ciapała, Wioletta Makuch · 2026

Early effects of a novel 5-HT 4 R agonist (PF-04995274) and the SSRI citalopram on emotional cognition in unmedicated depression: RESTAND study Amy Gillespie, Angharad N. de Cates, J.D. Scaife, Merethe Blandhol, Marieke A. G. Martens · 2026

Prevalence of propranolol use and self-prescription and its association with anxiety among medical students in Egypt: a cross-sectional study Mohamed Mohamed Belal, Basma Badrawy Khalefa, Mohamed Nabih Bashir, Ali A. Sayed, Abdallah Ahmad Khatatbeh · 2026

Our age of anxiety: fear, unease and worry David S. Baldwin, Nathan T. M. Huneke, Simon J. C. Davies, Nicky Lidbetter, Katharina Domschke · 2026

Drugs for anxiety: from chloral hydrate to novel therapeutics Peter M. Haddad · 2026

Identification of disproportionate reporting signals for ectopic pregnancy in the <scp>FAERS</scp> database from 2004 to 2024: A real‐world pharmacovigilance study Lixia Fu, Jia Xu · 2026

Safety profile and potential clinical risks of xanomeline and trospium chloride: A real-world pharmacovigilance study using FAERS Zhuocheng Bao, Yakun Liu, Yakun Liu, Yuxiang Liu, Yuxiang Liu · 2026

Improving patient safety through medicine risk communication: a theory-informed evaluation approach Anna V. Chatzi · 2026

Maternal and neonatal complications associated with breast cancer systemic treatments: A VigiBase disproportionality analysis study. Rayan Kabirian, Floriane Jochum, Élise Dumas, Florence Coussy, Kévin Bihan · 2026

Comparative Analysis of L-Carnitine and Coenzyme Q10 Adverse Reaction Reports Using the EudraVigilance Database: Implications for Health and Sports Supplementation Debora Di Mauro, Fabrizio Calapai, Ilaria Ammendolia, Mariaconcetta Currò, Fabio Trimarchi · 2026

Expert Panel Consensus Guidelines of the German Society of Neuroradiology on the Use of Magnetic Resonance Imaging in the Diagnosis and Monitoring of Multiple Sclerosis Mike P. Wattjes, Carsten Lukas, S Langner, Hagen H. Kitzler, Michael Scheel · 2026

Cardiovascular adverse events associated with bispecific antibodies in relapsed or refractory B-cell non-Hodgkin lymphomas Malak Munir, Ahmed Sayed, Dae Hyun Lee, Farrukh Awan, Sanam Ghazi · 2026

Itraconazole-Associated Fixed Drug Eruption in a Patient With Allergic Bronchopulmonary Aspergillosis: A Case Report and Review of the Literature Reshma S Thomas, Girish Joseph, Neena Bhatti, Dinesh K Badyal · 2026

Avacopan-Associated Hepatotoxicity: Clinical Signal, Liver Injury Patterns, and Plausible Mechanisms Luis Guillermo Herrera-Jiménez, Sebastián Arguedas-Chacón, Jeaustin Mora-Jiménez, Esteban Zavaleta‐Monestel · 2026

Balancing the benefits and risks of GLP-1 receptor agonists: a clinical guide for shared decision-making Areesha Moiz, Tricia M. Peters, Michael A. Tsoukas, Oriana H. Y. Yu, Kristian B. Filion · 2026

An Updated 16-Year Pharmacovigilance Analysis of Neuropsychiatric Safety Profiles of Ciprofloxacin, Levofloxacin, and Moxifloxacin Using FAERS Data Aura Rusu, Ioana-Maria Stroia, Marius Călin Cherecheș · 2026

Motif-Level Graph Learning Enables Interpretable Prediction of Drug-Induced QT Prolongation via Cooperative Substructural Determinants Wulin Long, Song Zhai, Yuheng Liu, M Li, Z Wen · 2026

Association between CRP rs1800947 genotypes, dexamethasone use, postoperative CRP level and morbidity in adult cardiac surgical patients in post-hoc analysis of the observational INFLACOR cohort trial Maciej Michał Kowalik, Romuald Lango, Maciej Brzeziński, Magdalena Chmara, Andrzej Łoś · 2026

Serum proteomic signatures and an immune-calcium signaling cascade associated with antipsychotic-related erectile dysfunction in schizophrenia Y Zhou, Shengwei Wu, Xuan Wen, Yue Wang, Jun-rong Ye · 2026

Letter to the Editor Regarding “Safety of Short‐Term Trimethoprim–Sulfamethoxazole Use for Uncomplicated Cystitis: A Nationwide Retrospective Cohort Study” Toshiki Fukasawa, Hisashi Urushihara, Takayuki Okura, Koji Kawakami · 2026

Cutaneous Adverse Drug Reactions Associated With BRAF and MEK Inhibitors: A Real‐World Analysis of WHO Pharmacovigilance Data Natalia Sauer, Piotr Giedziun, Jacek Calik, Anna Wiela‐Hojeńska · 2026

Evaluating community pharmacists’ knowledge, attitudes, and practices toward nutritional counselling and healthy lifestyles: evidence from a lower-middle-income country Lana Hanaysheh, Sondos Rajab, Tala Masri, Dania Abuhalima, Samah W. Al-Jabi · 2026

Metabolic fate and detectability of three novel fluoroprolintane psychostimulants: in vitro and in vivo characterization by hyphenated mass spectrometry Lea Wagmann, Anica Herter, Michael B. Dybek, Adeboye Adejare, Jason Wallach · 2026

Real-World Safety and Effectiveness of Lasmiditan in Patients with Migraine: A Post-Marketing Observational Study in Japan Naoko Sanno, Kevin Y. Urayama, Joji Mori, Kenichi Yoshizawa, Chie Hashimoto · 2026

Critical analysis of withdrawn drug applications in marketing authorization procedures of the European Medicines Agency (EMA) 2006–2024 Florian Hitsch, Roland Seifert · 2026

Biomedical Large Language Models and Prompt Engineering for Causality Assessment of Individual Case Safety Reports in Pharmacovigilance Nicole Sonne Heckmann, Despoina Georgia Papoutsi, María Antonietta Barbieri, Vera Battini, Soren Norlin Molgaard · 2026

ПРЕДПРИНИМАТЕЛЬСТВО В ОБРАЗОВАНИИ ФАРМАЦИИ: НОВАЯ ПАРАДИГМА ПОДГОТОВКИ СПЕЦИАЛИСТОВ Файзуллаева Хурлиман Куатовна · 2025

ПРИМЕНЕНИЕ ЦВЕТКОВ CARTHAMUS TINCTORIUS L. (САФЛОРА КРАСИЛЬНОГО) В ФАРМАЦИИ Ризаева Нилуфар Мухутдиновна, Бахриддинова Дилноза, Арипова Нозима Хакимжановна · 2024

Стандартизация в фармации как индикатор развития экономики медицины Погребинская Е. А., Гегечкори В. И., Петричева А. С. · 2025

КАЧЕСТВО ОБСЛУЖИВАНИЯ НАСЕЛЕНИЯ В АПТЕКАХ МОГИЛЕВСКОГО РУП «ФАРМАЦИЯ» Н. В. Иванчикова, Е. А. Романенко · 2024

Efficacy and safety of cell-based therapies for drug-resistant epilepsy: a systematic review of human studies Amirali Latifian, Javad Akhondian, Farah Ashrafzade, Narges Hashemi, Arshia Khalesi · 2026

Web questionnaire survey of physicians and patients on the side effects of trifluridine/tipiracil Takako Eguchi Nakajima, Ryota Okude, Takuma Tone, Ayako Oshika, Ayako Yokomizo · 2026

Research progress of biological processing of traditional Chinese medicine:fermentation and sprouting Jia-Qi Shi, Xiao-ting Wang, Jia-li Tian, Yu Shi, Wang Ya-zhu · 2026

Reply to: Re‐Examining Sedative and Hypnotic Prescribing Following Hip Fracture Meng Pan, Elyse M. Miller, Qoua L. Her, Virginia Pate, K. Faurot · 2026

Diagnosis of acetaminophen and codeine poisoning in a dog using earwax analysis by headspace gas chromatography-mass spectrometry (HS/GC-MS) Monica Chacon de Vicente, Alexandre Có Mangoni Barros, Gabriela Scarpin de Souza, L Junqueira de Almeida Prado, João Marcos G. Barbosa · 2026

Historical evolution and molecular mechanisms of antimalarial drug resistance with emerging challenges and future directions Osazuwa John Patrick, Adewale Allen Sokan‐Adeaga, Rachael Olaide Emmanuel · 2026

Alternative Clinical Careers for Physicians: A Mentor-Focused Study of Medical Science Liaison Career Awareness During a Wilderness Medicine Program in Chamonix-Mont-Blanc, France S. S. Dyer, Richard Ingebretsen, Jeff Kraemer · 2026

How to Flourish during the Menopausal Transition: A Scoping Review on Emotional, Social and Psychological Wellbeing Isabelle F Klukas, Marijke Schotanus-Dijkstra · 2026

A randomized controlled trial of adjunctive speleotherapy in asthma, COPD and long COVID Joachim Schwarz, Madelaine Eicke, Nina Schwedler, Gerrit von Komorowski, Verena Goldfuss · 2026

Effects of a cardiac rehabilitation program on anthropometric and functional parameters: an observational pre-post study Estrella García-Sánchez, Mirian Santamaría-Peláez, Jerónimo J. González-Bernal, Josefa González‐Santos, Jessica Fernández-Solana · 2026

A retrospective analysis of gastrointestinal adverse events associated with nicorandil using the FDA Adverse Event Reporting System (FAERS) following STROBE guidelines Chen Chen, Daying Long, Yunhong Lei, Luhuan Yang, Rong Zhang · 2026

Artificial Intelligence in Pharmacovigilance: Revolutionizing Drug Safety Monitoring Through Machine Learning and Natural Language Processing Sachin Sharma, Harsh Goswami, Birender Singh, Reenu Chauhan, KM Nisha · 2026

Dysesthesia associated with GLP-1 agonist therapies: data-mining analysis and literature review Marie-Laure Laroche, Hélène Geniaux, Manon Jardou · 2026

Antibiotic-Induced Pulmonary Fibrosis: National Database Analysis О. И. Бутранова, Yury Kustov, Anna Abramova, Sergey Zyryanov, Irina Asetskaya · 2026

Beyond the Expected: Rare Immune-Related Neuromuscular Toxicities of Checkpoint Inhibitors—A Real-World Experience M. Vyas, Satyam Patel, Manasi Shah, Vruddhi Patel, Akshar Naik · 2026

Safety and Effectiveness of Guanfacine Hydrochloride Extended-Release in Adult Patients with ADHD in Japan: A Post-Marketing Surveillance Study Akira Iwanami, Katsuaki Shirai, Hiroyuki Ida · 2026

Exploring Microbiota-Based Interventions for Different System Diseases: Adjuncts to Targeted Pharmaceutical Therapies Desiree Virginia Fermin Olivares, Tyler Halverson, Kannayiram Alagiakrishnan · 2026

Evaluating the effectiveness of motivational interviewing techniques on medication adherence in patients with glaucoma: A systematic review Bintu Mohammed Lamba, Mustapha Bature · 2026

Evaluation of time to first adverse drug reaction among treatment-experienced adult persons living with HIV/AIDS: a retrospective cohort study Erick Wesley Hedima, Adamu Umar Abubakar · 2026

Quality of adverse drug reaction reports submitted to the national pharmacovigilance center of Nepal: a pre- and post-training evaluation Sushil Nepal, Shyam Shah, Narayan Prasad Dhakal, Umanga Tripathee, Santusta Adhikari · 2026

Gastrointestinal manifestations of systemic lupus erythematosus (SLE): A comprehensive literature review Wojciech Bajurny, Julia Grabowska, Amelia Pielech, Natalia Struzik, Jakub Mastalerz · 2026

Probiotics in the Prevention and Management of Antibiotic-Resistant Infections Mahdi Marzi, Ayşe Karacalı Tunç · 2026

Reducing Inappropriate Polypharmacy Ian Scott, Sarah N. Hilmer, Emily Reeve, Kathleen N. Potter, David G. Le Couteur · 2015

A Randomized, Controlled Trial of Ebola Virus Disease Therapeutics Sabué Mulangu, Lori E. Dodd, Richard T. Davey, Olivier Tshiani Mbaya, Michael A. Proschan · 2019

Adjuvant Olaparib for Patients with BRCA1 - or BRCA2 -Mutated Breast Cancer Andrew Tutt, Judy E. Garber, Bella Kaufman, Giuseppe Viale, Debora Fumagalli · 2021

Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome Orrin Devinsky, J. Helen Cross, Linda Laux, Eric D. Marsh, Ian Miller · 2017

2016 ESC Position Paper on Cancer Treatments and Cardiovascular Toxicity Developed Under the Auspices of the ESC Committee for Practice Guidelines José Luis Zamorano, Patrizio Lancellotti, Daniel Muñoz, Victor Aboyans, Riccardo Asteggiano · 2016

Interventional strategies for pulmonary arterial hypertension: Current perspectives and future directions Konstantinos Platanias, Stergios Soulaidopoulos, Marios Sagris, Athanasios Makris, Sofia Touriki · 2026

Levofloxacin versus moxifloxacin in nitazoxanide-based quadruple therapy as a first-line treatment for Helicobacter pylori infection: NILE, a randomized, comparative, multicenter study Gasser El-Azab, Sherief Abdel Salam, Ehab Moustafa, Ahmed Abuoelhassan, Ayman Shamseya · 2026

Adverse Drug Reaction Costs and Study Quality in Africa: A Systematic Review of Cost-of-Illness Studies Bezie Kebede, Bereket Bahiru, Chernet Tafere · 2026

Hypotensive Events Associated With PDE-5 Inhibitors in Pulmonary Arterial Hypertension: Assessment of the USFDA Adverse Event Reporting System Using Disproportionality and Interaction Analysis Kannan Sridharan, Gowri Sivaramakrishnan · 2026

From postmortem to pre-emptive: a framework for genomic integration within the UK Yellow Card scheme Michael Wahba · 2026

2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines José Luis Zamorano, Patrizio Lancellotti, Daniel Muñoz, Victor Aboyans, Riccardo Asteggiano · 2016

Fatal Toxic Effects Associated With Immune Checkpoint Inhibitors Daniel Wang, Joe‐Elie Salem, Justine V. Cohen, Sunandana Chandra, Christian Menzer · 2018

Revolutionizing healthcare: the role of artificial intelligence in clinical practice Shuroug A. Alowais, Sahar S. Alghamdi, Nada Alsuhebany, Tariq Alqahtani, Abdulrahman Alshaya · 2023

The growing use of herbal medicines: issues relating to adverse reactions and challenges in monitoring safety Martins Ekor · 2014

The REporting of studies Conducted using Observational Routinely-collected health Data (RECORD) Statement Eric I. Benchimol, Liam Smeeth, Astrid Guttmann, Katie Harron, David Moher · 2015

Adjuvant Pembrolizumab versus Placebo in Resected Stage III Melanoma Alexander M.M. Eggermont, Christian U. Blank, Mario Mandalà, Georgina V. Long, Victoria Atkinson · 2018

Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care Marc D. Binder, Christoph U. Correll, Julio Bobes, Marcelo Cetkovich, Dan Cohen · 2011

Pharmacovigilance of semaglutide: A descriptive analysis of WHO-VigiAccess reports Nasser M. Alorfi, Mansour M. Alourfi, Ammar AlDabbagh, Waleed Saleh Alghamdi, Sarah S. Al Ghamdi · 2026

Consensus statement on the application of artificial intelligence in osteoporosis screening and management: perspectives from the Asia-Pacific region Chun‐Feng Huang, Wen-Hui Fang, Kun-Hui Chen, Sung-Yen Lin, C K Ho · 2026

Age‐Dependent Cardiovascular Adverse Event Reporting With Pathway‐Directed Anticancer Therapies in Children and Adults: A VigiBase Disproportionality Analysis Fabien Labombarda, Damien Bodet, Jérémie Rouger, C Guerin, Marion Sassier · 2026

Modern Therapeutic Strategies in Rheumatoid Arthritis AND Other Autoimmune Diseases A. G. (Abduganieva) qizi · 2026

Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: ASCO Guideline Update Bryan J. Schneider, Jarushka Naidoo, Bianca D. Santomasso, Christina Lacchetti, Sherry Adkins · 2021

Molecular Docking: Shifting Paradigms in Drug Discovery Luca Pinzi, Giulio Rastelli · 2019

The Traditional Medicine and Modern Medicine from Natural Products Hai-Dan Yuan, Qianqian Ma, Ye Li, Guangchun Piao · 2016

PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews Matthew J. Page, David Moher, Patrick M. Bossuyt, Isabelle Boutron, Tammy Hoffmann · 2021

Pharmacological interventions for somatoform disorders in adults Maria Kleinstäuber, Michael Witthöft, Andrés Steffanowski, Harm van Marwijk, Wolfgang Hiller · 2014

Sustained Hematological Stability During Clozapine Rechallenge With Adjunctive Lithium: A Case Report of 15-Month Follow-Up Karim Hamda, Azeddine Barkiat, Siham Belbachir, Abderrazzak Ouanass · 2026

COMPLIANCE WITH JNC-8 GUIDELINES IN ANTIHYPERTENSIVE PRESCRIBING: EVIDENCE FROM A SOUTHERN NIGERIAN TERTIARY HOSPITAL Samuel Emeka O. Chukwuma · 2026

Evidence synthesis methods for overcoming data scarcity in child health research: a focus on antiemetic medications for preventing chemotherapy-induced nausea and vomiting in children Ruth Walker · 2026

TaIlored ManagEment of Sleep (TIMES) for people with dementia and mild cognitive impairment in primary care in England: protocol for a feasibility cluster-randomised controlled trial Jayden van Horik, Louise Allan, Aidin Aryankhesal, Niall M. Broomfield, P Greenstreet · 2026

Концепция пациентоориентированности в медицине и фармации Хохлов Александр Леонидович, Сычев Дмитрий Алексеевич · 2023

СУЛЬФОЛИТОХОЛЕВАЯ КИСЛОТА: ПЕРСПЕКТИВЫ ИСПОЛЬЗОВАНИЯ В ВЕТЕРИНАРНОЙ ФАРМАЦИИ Понамарёв В. С. · 2024

ИСПОЛЬЗОВАНИЕ НАГЛЯДНО-ДЕМОНСТРАЦИОННЫХ И ПРОБЛЕМНО-ПОИСКОВЫХ МЕТОДОВ ОБУЧЕНИЯ НА ЗАНЯТИЯХ ПО УЧЕБНОМУ ПРЕДМЕТУ «ОРГАНИЗАЦИЯ И ЭКОНОМИКА ФАРМАЦИИ» Карпенко О. В. · 2023

АКТУАЛЬНЫЕ АСПЕКТЫ ПЕРВИЧНОЙ АККРЕДИТАЦИИ СПЕЦИАЛИСТОВ ФАРМАЦИИ: ОПЫТ И ПРАКТИКА ТЮМЕНСКОГО ГОСУДАРСТВЕННОГО МЕДИЦИНСКОГО УНИВЕРСИТЕТА Родина Юлия Сергеевна, Викулова Ксения Анатольевна, Черкасова (бышенко) Виктория Владимировна, Русакова Ольга Александровна · 2025